← Leaderboards
Esteban Braggio
Mayo Clinic Rochester
$6,330,549
Attributed
$12,297,749
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,297,749 · 5
By mechanism
R01$10,564,541 · 3
P50$1,733,208 · 2
Top collaborators
- Susan L Slager14 shared
- Christopher C. Oakes4 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Susan L Slager$16,375,515
- Tait D Shanafelt$9,008,119
- Amy C Degnim$9,208,153
- Hilal Maradit Kremers$11,722,206
- V. Shane Pankratz$4,461,337
Others in their field
Other Emerging Leaders on “Genetic”
- Leonard Freedman · Leidos Biomedical Research, Inc.$89,060,933
- Ted Ross · University Of Georgia$68,763,143
- Scott Topper · Broad Institute, Inc.$64,989,588
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Dale Sandler · Social And Scientific Systems, Inc.$43,209,852
Research focus
GeneticGenesTumorTranscriptomicsWhole GenomeVariantBiologicalInsightGenomicsGenome Wide Association StudyMutateSusceptibility GeneSingle Nucleotide PolymorphismMutationInheritedGenotypeChronic Lymphocytic LeukemiaLeukemiaTargeted SequencingSomatic MutationEpigenetic ProcessEtiologyPublic HealthGenome Sequencing
Grant awards (19)
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)$1,651,283
R01 · FY2025 · CA
Germline and Somatic Genomic Studies in CLL$662,342
R01 · FY2025 · CA
Project 2: Multi-Omics of high-risk MM$370,311
P50 · FY2025 · CA · contact PI
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)$783,300
R01 · FY2024 · CA
Germline and Somatic Genomic Studies in CLL Minorities$629,224
R01 · FY2024 · CA
Project 2: Multi-Omics of high-risk MM$349,066
P50 · FY2024 · CA · contact PI
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)$804,919
R01 · FY2023 · CA
Germline and Somatic Genomic Studies in CLL Minorities$649,094
R01 · FY2023 · CA
Integration of germline and tumor genomes in CLL$622,223
R01 · FY2023 · CA
Project 2: Multi-Omics of high-risk MM$339,786
P50 · FY2023 · CA · contact PI
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)$870,073
R01 · FY2022 · CA
Germline and Somatic Genomic Studies in CLL Minorities$649,094
R01 · FY2022 · CA
Integration of germline and tumor genomes in CLL$633,873
R01 · FY2022 · CA
Project 2: Multi-Omics of high-risk MM$321,593
P50 · FY2022 · CA · contact PI
Germline and Somatic Genomic Studies in CLL Minorities$677,092
R01 · FY2021 · CA
Integration of germline and tumor genomes in CLL$639,092
R01 · FY2021 · CA
Project 2: Multi-Omics of high-risk MM$352,452
P50 · FY2021 · CA · contact PI
Integration of germline and tumor genomes in CLL$639,092
R01 · FY2020 · CA
Integration of germline and tumor genomes in CLL$653,840
R01 · FY2019 · CA